Plaintiffs Drop Lipitor Class Action Against Pfizer
Plaintiffs have dropped their putative class action accusing Pfizer Inc. of fraudulently marketing Lipitor by covering up certain side effects and misrepresenting the cholesterol drug's efficacy in some patient groups....To view the full article, register now.
Already a subscriber? Click here to view full article